Can-Fite BioPharma Announces Clinical and Corporate Developments for Near-Term Events
22 oct. 2013 15h10 HE
|
Can-Fite BioPharma
PETACH TIKVA, ISRAEL--(Marketwired - Oct 22, 2013) - Can-Fite BioPharma (TASE: CFBI), (OTCQB: CANFY), a biotechnology company with a pipeline of proprietary small molecule drugs that address...
Oxis International Inc Receives GRAS Status for its Patented L-Ergothioneine Anti-Oxidant
10 oct. 2011 08h30 HE
|
OXIS International Inc.
Beverly Hills, California, Oct. 10, 2011 (GLOBE NEWSWIRE) -- Oxis International Inc. (OTC/Bulletin Board: OXIS.OB and Euronext: OXI.PA) today announced that an independent scientific panel of experts...